BridgeBio Pharma, Inc. Interest Expense (Operating)

Interest Expense (Operating) of BBIO for past 10 years: annual, quarterly and twelve month trailing (TTM) including Interest Expense (Operating) growth rates and interactive chart.


Highlights and Quick Summary

  • Interest Expense (Operating) for the quarter ending September 30, 2022 was $19.8 Million (a -2.24% decrease compared to previous quarter)
  • Year-over-year quarterly Interest Expense (Operating) increased by 31.0%
  • Annual Interest Expense (Operating) for 2021 was $46.8 Million (a 27.62% increase from previous year)
  • Annual Interest Expense (Operating) for 2020 was $36.7 Million (a 318.2% increase from previous year)
  • Annual Interest Expense (Operating) for 2019 was $8.77 Million (a 244.13% increase from previous year)
  • Twelve month Interest Expense (Operating) ending September 30, 2022 was $75.6 Million (a 13.11% increase compared to previous quarter)
  • Twelve month trailing Interest Expense (Operating) increased by 61.58% year-over-year
Trailing Interest Expense (Operating) for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
$75.6 Million $66.8 Million $57.4 Million $46.8 Million
Visit stockrow.com/BBIO for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Interest Expense (Operating) of BridgeBio Pharma, Inc.

Most recent Interest Expense (Operating)of BBIO including historical data for past 10 years.

Interactive Chart of Interest Expense (Operating) of BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc. Interest Expense (Operating) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $19.83 $20.28 $20.34
2021 $15.13 $11.07 $10.84 $9.74 $46.78
2020 $10.96 $10.93 $10.75 $4.01 $36.66
2019 $3.04 $8.77
2018 $2.55
2017 $0.01

Business Profile of BridgeBio Pharma, Inc.

Sector: Healthcare
Industry: Biotechnology